1,2-dimethylhydrazine multiple interactions EXP 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of PHLDB2 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1 and 2-Dimethylhydrazine results in increased expression of PHLDB2 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 Estradiol results in decreased expression of PHLDB2 mRNA CTD PMID:32145629 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO PHLDB2 (Homo sapiens) 6480464 Dihydrotestosterone results in increased expression of PHLDB2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PHLDB2 mRNA CTD PMID:19770486 and PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PHLDB2 mRNA CTD PMID:32109520 and PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PHLDB2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO PHLDB2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of PHLDB2 mRNA CTD PMID:20106945 and PMID:21632981 2-hydroxypropanoic acid increases expression ISO PHLDB2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of PHLDB2 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of PHLDB2 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression EXP 6480464 bisphenol S results in increased expression of PHLDB2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO PHLDB2 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of PHLDB2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of PHLDB2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of PHLDB2 mRNA CTD PMID:24780913 and PMID:25825206 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PHLDB2 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO PHLDB2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of PHLDB2 gene CTD PMID:27153756 antirheumatic drug increases expression ISO PHLDB2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of PHLDB2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO PHLDB2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of PHLDB2 mRNA CTD PMID:33212167 arsenous acid increases expression ISO PHLDB2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of PHLDB2 mRNA CTD PMID:20458559 atrazine affects methylation ISO Phldb2 (Rattus norvegicus) 6480464 Atrazine affects the methylation of PHLDB2 gene CTD PMID:35440735 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of PHLDB2 mRNA CTD PMID:19770486 benzo[a]pyrene decreases methylation ISO PHLDB2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of PHLDB2 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO PHLDB2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of PHLDB2 exon and Benzo(a)pyrene affects the methylation of PHLDB2 promoter CTD PMID:27901495 and PMID:30157460 benzo[a]pyrene decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of PHLDB2 protein CTD PMID:32717239 benzo[a]pyrene diol epoxide I decreases expression ISO PHLDB2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PHLDB2 mRNA CTD PMID:26063408 more ... bisphenol A multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PHLDB2 gene CTD PMID:31601247 bisphenol A affects methylation ISO PHLDB2 (Homo sapiens) 6480464 bisphenol A affects the methylation of PHLDB2 gene CTD PMID:31601247 bisphenol A decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of PHLDB2 mRNA CTD PMID:25181051 more ... bisphenol F increases expression EXP 6480464 bisphenol F results in increased expression of PHLDB2 mRNA CTD PMID:30951980 butanal decreases expression ISO PHLDB2 (Homo sapiens) 6480464 butyraldehyde results in decreased expression of PHLDB2 mRNA CTD PMID:26079696 cadmium dichloride increases expression ISO PHLDB2 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of PHLDB2 mRNA CTD PMID:26472689 caffeine affects phosphorylation ISO PHLDB2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of PHLDB2 protein CTD PMID:35688186 calcitriol increases expression ISO PHLDB2 (Homo sapiens) 6480464 Calcitriol results in increased expression of PHLDB2 mRNA CTD PMID:16002434 cannabidiol increases expression ISO PHLDB2 (Homo sapiens) 6480464 Cannabidiol results in increased expression of PHLDB2 mRNA CTD PMID:33244087 carbamazepine affects expression ISO PHLDB2 (Homo sapiens) 6480464 Carbamazepine affects the expression of PHLDB2 mRNA CTD PMID:25979313 CGP 52608 multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to PHLDB2 gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PHLDB2 mRNA CTD PMID:37019170 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PHLDB2 gene CTD PMID:20938992 cisplatin multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PHLDB2 mRNA CTD PMID:27392435 cisplatin decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of PHLDB2 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO PHLDB2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of PHLDB2 mRNA CTD PMID:19320972 copper atom multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of PHLDB2 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO PHLDB2 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of PHLDB2 protein CTD PMID:35688186 coumestrol multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos decreases expression EXP 6480464 Asbestos and Crocidolite results in decreased expression of PHLDB2 mRNA CTD PMID:29279043 crocidolite asbestos decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Asbestos and Crocidolite results in decreased expression of PHLDB2 mRNA CTD PMID:29523930 cyclosporin A decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of PHLDB2 mRNA CTD PMID:20106945 cyclosporin A affects expression ISO PHLDB2 (Homo sapiens) 6480464 Cyclosporine affects the expression of PHLDB2 mRNA CTD PMID:25562108 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of PHLDB2 mRNA CTD PMID:22733784 diarsenic trioxide increases expression ISO PHLDB2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of PHLDB2 mRNA CTD PMID:20458559 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of PHLDB2 mRNA CTD PMID:17361019 and PMID:21266533 disulfiram multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in increased expression of PHLDB2 mRNA CTD PMID:24690739 diuron decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 Diuron results in decreased expression of PHLDB2 mRNA CTD PMID:25152437 dorsomorphin multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDB2 mRNA CTD PMID:27188386 Enterolactone multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of PHLDB2 mRNA CTD PMID:19167446 ethyl methanesulfonate decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of PHLDB2 mRNA CTD PMID:23649840 fenamidone increases expression EXP 6480464 fenamidone results in increased expression of PHLDB2 mRNA CTD PMID:27029645 folic acid multiple interactions EXP 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 FR900359 affects phosphorylation ISO PHLDB2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of PHLDB2 protein CTD PMID:37730182 fulvestrant multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PHLDB2 gene CTD PMID:31601247 fulvestrant increases methylation ISO PHLDB2 (Homo sapiens) 6480464 Fulvestrant results in increased methylation of PHLDB2 gene CTD PMID:31601247 geldanamycin increases expression ISO PHLDB2 (Homo sapiens) 6480464 geldanamycin results in increased expression of PHLDB2 mRNA CTD PMID:26705709 glyphosate decreases methylation ISO Phldb2 (Rattus norvegicus) 6480464 Glyphosate results in decreased methylation of PHLDB2 gene CTD PMID:31011160 hexadecanoic acid decreases phosphorylation ISO PHLDB2 (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of PHLDB2 protein CTD PMID:28073184 isobutanol multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of PHLDB2 mRNA CTD PMID:29432896 ivermectin decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of PHLDB2 protein CTD PMID:32959892 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of PHLDB2 gene CTD PMID:20938992 Licochalcone B decreases expression ISO PHLDB2 (Homo sapiens) 6480464 licochalcone B results in decreased expression of PHLDB2 mRNA CTD PMID:33647349 lipopolysaccharide multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PHLDB2 mRNA CTD PMID:35811015 melphalan decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Melphalan results in decreased expression of PHLDB2 mRNA CTD PMID:22363485 nefazodone decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 nefazodone results in decreased expression of PHLDB2 mRNA CTD PMID:24136188 nimesulide decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 nimesulide results in decreased expression of PHLDB2 mRNA CTD PMID:24136188 ochratoxin A decreases expression ISO PHLDB2 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of PHLDB2 mRNA CTD PMID:30559759 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of PHLDB2 mRNA CTD PMID:17562736 paracetamol decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of PHLDB2 mRNA CTD PMID:21420995 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PHLDB2 mRNA CTD PMID:23091169 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of PHLDB2 mRNA CTD PMID:18445702 quercetin decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Quercetin results in decreased expression of PHLDB2 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO PHLDB2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of PHLDB2 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of PHLDB2 mRNA CTD PMID:19167446 rotenone increases expression ISO Phldb2 (Rattus norvegicus) 6480464 Rotenone results in increased expression of PHLDB2 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of PHLDB2 mRNA CTD PMID:35811015 SB 431542 multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDB2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO PHLDB2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of PHLDB2 mRNA CTD PMID:25895662 silver atom increases expression ISO PHLDB2 (Homo sapiens) 6480464 Silver results in increased expression of PHLDB2 mRNA CTD PMID:28959546 silver atom decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Silver results in decreased expression of PHLDB2 mRNA CTD PMID:26551752 silver(0) increases expression ISO PHLDB2 (Homo sapiens) 6480464 Silver results in increased expression of PHLDB2 mRNA CTD PMID:28959546 silver(0) decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Silver results in decreased expression of PHLDB2 mRNA CTD PMID:26551752 sodium arsenite decreases expression ISO PHLDB2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of PHLDB2 mRNA CTD PMID:12679051 and PMID:34032870 sunitinib decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of PHLDB2 mRNA CTD PMID:31533062 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of PHLDB2 mRNA CTD PMID:17484886 and PMID:31919559 tetrachloromethane decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in decreased expression of PHLDB2 mRNA CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PHLDB2 mRNA CTD PMID:27339419 thimerosal decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Thimerosal results in decreased expression of PHLDB2 mRNA CTD PMID:27188386 thioacetamide affects expression ISO Phldb2 (Rattus norvegicus) 6480464 Thioacetamide affects the expression of PHLDB2 mRNA CTD PMID:34492290 titanium dioxide affects expression EXP 6480464 titanium dioxide affects the expression of PHLDB2 mRNA CTD PMID:23557971 trichloroethene decreases expression ISO Phldb2 (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of PHLDB2 mRNA CTD PMID:33387578 trichostatin A increases expression ISO PHLDB2 (Homo sapiens) 6480464 trichostatin A results in increased expression of PHLDB2 mRNA CTD PMID:24935251 triclosan increases expression ISO PHLDB2 (Homo sapiens) 6480464 Triclosan results in increased expression of PHLDB2 mRNA CTD PMID:30510588 triphenyl phosphate increases expression ISO Phldb2 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of PHLDB2 mRNA CTD PMID:30589522 triptonide increases expression EXP 6480464 triptonide results in increased expression of PHLDB2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO PHLDB2 (Homo sapiens) 6480464 troglitazone results in decreased expression of PHLDB2 mRNA CTD PMID:25572481 urethane decreases expression ISO PHLDB2 (Homo sapiens) 6480464 Urethane results in decreased expression of PHLDB2 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO PHLDB2 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of PHLDB2 gene CTD PMID:29154799 valproic acid affects expression ISO PHLDB2 (Homo sapiens) 6480464 Valproic Acid affects the expression of PHLDB2 mRNA CTD PMID:25979313 valproic acid increases expression ISO PHLDB2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of PHLDB2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO PHLDB2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHLDB2 mRNA CTD PMID:27188386 vorinostat affects expression ISO PHLDB2 (Homo sapiens) 6480464 vorinostat affects the expression of PHLDB2 mRNA CTD PMID:27188386
